Cointime

Navigenics

company

About

Navigenics is a personal genomics company that uses genetic testing to help people determine their individual risk for health conditions.

  • 11 - 50

Highlights

Total Funding Amount
$43M
Funding Rounds
2
Investors
2

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$25M
Industries
Biotechnology,Genetics,Health Care,Pet
Founded date
Jan 1, 2006
Number Of Employee
11 - 50
Operating Status
Active

Navigenics, Inc. helps educate and empower individuals and their physicians with knowledge of their genetic predispositions, and then motivates them to act on the information to prevent the onset of disease, achieve earlier diagnosis, appropriately manage disease, or otherwise lessen its impact. Navigenics' lead investors are Kleiner Perkins Caufield and Byers, Sequoia Capital and MDV-Mohr Davidow Ventures.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$43M
Navigenics has raised a total of $43M in funding over 2 rounds. Their latest funding was raised on Feb 4, 2010 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 4, 2010 Series C $18M 1 — — Detail
Nov 7, 2007 Series Unknown $25M 1 Sequoia Capital — Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Navigenics is funded by 2 investors. Sequoia Capital and Procter & Gamble Company are the most recent investors.
Investor Name Lead Investor Funding Round
Sequoia Capital Yes Series Unknown
Procter & Gamble Company — Series C
Cointime
Содержание
компания